Drug Shortage Report for APO-CANDESARTAN

Last updated on 2020-02-25 History
Report ID 18517
Drug Identification Number 02365340
Brand name APO-CANDESARTAN
Common or Proper name CANDESARTAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) CANDESARTAN CILEXETIL
Strength(s) 4MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-07
Estimated end date 2020-02-28
Actual end date 2020-02-21
Shortage status Resolved
Updated date 2020-02-25
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2020-02-25 French Compare
v17 2020-02-25 English Compare
v16 2020-02-06 French Compare
v15 2020-02-06 English Compare
v14 2019-04-08 French Compare
v13 2019-04-08 English Compare
v12 2018-11-30 French Compare
v11 2018-11-30 English Compare
v10 2018-04-02 French Compare
v9 2018-04-02 English Compare
v8 2018-01-31 French Compare
v7 2018-01-31 English Compare
v6 2018-01-03 French Compare
v5 2018-01-03 English Compare
v4 2017-11-07 French Compare
v3 2017-11-07 English Compare
v2 2017-08-08 French Compare
v1 2017-08-08 English Compare